The specific price of Mobocertinib is currently affected by the purchase channel, regional policies, and medical insurance reimbursement. This drug must be used strictly according to the doctor's prescription; patients must use it under the guidance of a physician.
Price Influencing Factors:
Medical Insurance Coverage: If this drug is included in the local medical insurance or special drug reimbursement list, the patient's out-of-pocket expenses may be significantly reduced, with reimbursement rates reaching 50%-70% in some regions.
Purchase Channels: Prices may vary between hospital pharmacies, designated pharmacies, or those imported through compliant channels. It is recommended to obtain it through legitimate channels.
Dosage and Treatment Course: The drug specifications (e.g., 120mg × 30 tablets per box) and the treatment cycle will affect the total cost and need to be evaluated in conjunction with the individual treatment plan.
Drug Characteristics and Indications: Mobocertinib is a targeted therapy drug for EGFR exon 20 insertion mutation-positive non-small cell lung cancer, suitable for patients with locally advanced or metastatic lung cancer who have failed previous chemotherapy.
Clinical data shows that it has a good disease control effect on patients with specific gene mutations, but the efficacy varies from person to person, and applicability needs to be confirmed through genetic testing.
Medication and Precautions
Side Effect Management: Common adverse reactions include diarrhea, rash, nausea, etc. In severe cases, it may lead to interstitial lung disease or heart problems, requiring regular monitoring and timely medical attention.
Drug Accessibility: If it is not available in China or is temporarily unavailable, some patients can apply for "temporary import" through medical institutions or participate in clinical trials to obtain it.
Patient Assistance Programs: Some pharmaceutical companies or charitable organizations offer fee reductions or drug donation programs. Consult your attending physician or relevant platforms to learn about the application requirements.
Medical Guidance
After diagnosis, the treatment plan should be evaluated by an oncology specialist, and the suitability of targeted drugs should be determined based on the genetic testing results.
During medication, regular follow-up examinations (such as imaging examinations and blood indicator monitoring) are necessary as prescribed by the doctor to dynamically adjust the treatment strategy.
It is recommended that patients maintain communication with the medical team throughout the treatment process, choose an economically feasible medication plan based on their individual circumstances, and strictly follow the medication guidelines to ensure safety and effectiveness.
